Anavex Life Sciences Corp (AVXL)

[Anshu2]

This is promising. CM is being specific about the biomarker:

Soumit Roy:
Got you. So, you're going to show the amyloid's status baseline versus six months or 12 months' time point?

Christopher Missling

Yes, that's right. We have not only a beta, we have tau with other pathology and biomarkers of inflammation of neurodegeneration, and these are all instrumental in describing the pathway of the pathology. And if they do -- are making different outcomes with the drug intervention, then this is very significant information of the [drug itself] (ph).